IL18 and psoriasis: explored the possible pathological mechanisms of IL-18 in psoriasis and reported that IL-18 might exacerbate pronounced inflammation and impact pathological features to cause micro-abscesses and scale formation through upregulating pro-inflammatory cytokines and reducing protective cytokines in a mouse model of imiquimod-induced psoriasis (109).